4th International AIDS Malignancy Conference

Alexandra M. Levine, MD, University of Southern California School of Medicine, and Ellen Feigal, MD, US National Cancer Institute

Disclosures

Medscape HIV/AIDS eJournal. 2000;6(3) 

In This Article

Introduction

The 4th International AIDS Malignancy Conference, sponsored by the US National Cancer Institute (NCI), opened with a discussion of the current statistics related to HIV/AIDS around the world. As presented by Ellen Feigal, MD,[1] 33.6 million people had been diagnosed with AIDS worldwide by the end of 1999, with a total of 16.3 million deaths. New HIV infections reached 5.6 million worldwide in 1999 alone, with over 15,000 new infections per day. AIDS now causes 19% of all deaths in sub-Saharan Africa, and 4.2% of all deaths globally. It is within this setting that the current conference was convened, for the purposes of assessing the current state of our knowledge regarding the malignancies associated with HIV, and documenting any changes that may have occurred over time, with the use of highly active antiretroviral therapy (HAART), or both.

Made possible by an unrestricted educational grant from Ligand Pharmaceuticals.

Produced in association with

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....